Anavex Life Sciences Corp (AVXL)

[Hazel2323]

Two weeks until the end of October. The second week ahead, AVXL will have the CTAD conference. It is probable, but not 100% certain (remember the AAIC, but this time the event is about clinical trials; it makes more sense), that Anavex will reveal more data on the AD clinical trial in parallel (there is no confirmation of their participation) due to the media exposure during the event. And Rett month is coming to an end, so AVXL will likely get the results of the excellence trial as well.